PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors that regulate lipid and glucose metabolism and cellular differentiation. PPAR-alpha and PPAR-gamma are both expressed in human macrophages where they exert anti-inflammatory effects. The activation of PPAR-alpha may promote foam-cell formation by inducing expression of the macrophage scavenger receptor CD36. This prompted us to investigate the influence of different PPAR-activators on cholesterol metabolism and foam-cell formation of human primary and THP-1 macrophages. Here we show that PPAR-alpha and PPAR-gamma activators do not influence acetylated low density lipoprotein-induced foam-cell formation of human macrophages. In contrast, PPAR-alpha and PPAR-gamma activators induce the expression of the gene encoding ABCA1, a transporter that controls apoAI-mediated cholesterol efflux from macrophages. These effects are likely due to enhanced expression of liver-x-receptor alpha, an oxysterol-activated nuclear receptor which induces ABCA1-promoter transcription. Moreover, PPAR-alpha and PPAR-gamma activators increase apoAI-induced cholesterol efflux from normal macrophages. In contrast, PPAR-alpha or PPAR-gamma activation does not influence cholesterol efflux from macrophages isolated from patients with Tangier disease, which is due to a genetic defect in ABCA1. Here we identify a regulatory role for PPAR-alpha and PPAR-gamma in the first steps of the reverse-cholesterol-transport pathway through the activation of ABCA1-mediated cholesterol efflux in human macrophages.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This mechanism is pivotal in controlling intracellular lipid content and serves as a primary “gatekeeper” for reverse cholesterol transport in cells [23].”
From miR-223 accelerates lipid droplets clearance in microglia following spinal cord injury by upregulating ABCA1 (2024) · cites this paper as [23]
In the citing paper
“The activation of PPARα also accelerates reverse cholesterol transport (RCT) via increased expression of ABCA1 and ABCG1 transporters involved in cholesterol efflux from macrophages [29, 40].”
From Pemafibrate, a new selective PPARα modulator: drug concept and its clinical applications for dyslipidemia and metabolic diseases (2020) · cites this paper as [40]
Citations
Cites
A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES
Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630 · cited 1×
“, and this led to the suggestion that PPAR-activators may modulate foam-cell formation, a known atherogenic process characterized by cholesteryl-ester-droplet accumulation in the cytoplasm of macrophage”
BackgroundThe peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525
Rubins, H. B., Robins, S. J., Collins, D., Fye, C. L., Anderson, J. W., Elam, M. B., Faas, F. H., Linares, E., Schaefer, E. J., Schectman, G., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410604 · Cited by 3,439
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
Jiang, C., Ting, A. T., & Seed, B. (1998) · Nature · doi:10.1038/34184 · Cited by 2,899 · cited 1×
“Both PPAR-α and PPAR-γ are expressed in fully-differentiated human macrophages where they regulate genes implicated in the inflammatory response, modulate macrophage differentiation and promote TNF-α/IFN-γ–induced apoptosi”
BackgroundThe PPARs: From Orphan Receptors to Drug Discovery
Willson, T. M., Brown, P. J., Sternbach, D. D., & Henke, B. R. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990554g · Cited by 1,816 · cited 1×
“We treated these cells with either the PPAR-α ligand Wy14643 or the PPAR-γ ligand rosiglitazone at concentrations of 2–3 times their EC 50 values (Wy14643 EC 50 for human PPAR-αe25 μM and rosiglitazone EC 50 for human PPAR-γe43 nM”
PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL
Tontonoz, P., Nagy, L., Alvarez, J. G. A., Thomazy, V. A., & Evans, R. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81575-5 · Cited by 1,797 · cited 1×
“Moreover, PPAR-α activation results in the transcriptional induction of CD36 expression in macrophage”
BackgroundMechanism of Action of Fibrates on Lipid and Lipoprotein Metabolism
Staels, B., Dallongeville, J., Auwerx, J., Schoonjans, K., Leitersdorf, E., & Fruchart, J.-C. (1998) · Circulation · doi:10.1161/01.cir.98.19.2088 · Cited by 1,786 · cited 1×
“The stimulatory role of PPAR-α activators on hepatic HDL production and apoAI expression is well-documente”
BackgroundSelf-citationMutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
Brooks-Wilson, A., Marcil, M., Clee, S. M., Zhang, L.-H., Roomp, K., van Dam, M., Yu, L., Brewer, C., Collins, J. A., Molhuizen, H. O. F., et al. (1999) · Nature Genetics · doi:10.1038/11905 · Cited by 1,687
An oxysterol signalling pathway mediated by the nuclear receptor LXRα
Janowski, B. A., Willy, P. J., Devi, T. R., Falck, J. R., & Mangelsdorf, D. J. (1996) · Nature · doi:10.1038/383728a0 · Cited by 1,591 · cited 1×
“We also show that both PPAR-α and PPAR-γ activators induce ABCA1 expression, possibly through their inductive effects on expression of LXR-α, a nuclear receptor activated by oxysterol”
Background
Cited by
Items 701–800 of 1,000
Pakala, R., Dilcher, C. E., Baffour, R., Hellinga, D. G., Seabron, R., Joner, M., Kolodgie, F. D., Virmani, R., & Waksman, R. (2006) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000249891.40714.2a · Cited by 22
Amoruso, A., Bardelli, C., Fresu, L. G., Palma, A., Vidali, M., Ferrero, V., Ribichini, F. L., Vassanelli, C., & Brunelleschi, S. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.154419 · Cited by 22
“PPAR- has been indicated to exert a dual role, either pro- (Tontonoz et al., 1998) and antiatherogenic (Chawla et al., 2001; Chinetti et al., 2001), but, according to Lazar (2001), a net antiatherogenic can be envisaged.”
BackgroundGuan, J., Tamasawa, N., Murakami, H., Matsui, J., Yamato, K., & Suda, T. (2003) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.201.251 · Cited by 21
“LXR forms a heterodimeric complex with retinoid X receptor (RXR)(Tobin et al.2000;Chinetti et al.2001), and the complex,in turn,regulates the metabolism of lipids including cholesterol and bile acids (Wily et al.1995).”
BackgroundElias, A. N., & Lizotte, P. E. (2006) · Clinical Nuclear Medicine · doi:10.1097/01.rlu.0000233148.45744.44 · Cited by 21
Perez, A., Thuillard, J.-L., Bentzen, C. L., & Niesor, E. J. (2003) · Cell Biology and Toxicology · doi:10.1023/a:1023307206125 · Cited by 21
Genes potentially involved in plaque rupture
Faber, B. C. G., Heeneman, S., Daemen, M. J. A. P., & Cleutjens, K. B. J. M. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200210000-00011 · Cited by 21
Insights of High-Density Lipoprotein Apolipoprotein-Mediated Lipid Efflux from Cells
Lin, G. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6505 · Cited by 24
Hypertriglyceridemia: Associated Risks and Effect of Drug Treatment
Jonkers, I. J. A. M., Smelt, A. H. M., & van der Laarse, A. (2001) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200101060-00005 · Cited by 26
Malur, A., Huizar, I., Wells, G., Barna, B. P., Malur, A. G., & Thomassen, M. J. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.10.043 · Cited by 23
Fuior, E. V., Zvintzou, E., Filippatos, T. D., Giannatou, K., Mparnia, V., Simionescu, M., Gafencu, A. V., & Kypreos, K. E. (2023) · Biomedicines · doi:10.3390/biomedicines11102696 · Cited by 28
“Previous studies have suggested that either PPAR α [98] or PPAR γ [98,116] activation promotes HDL-mediated cholesterol efflux from macrophages by enhancing the expression of ABCA1.”
Lee, L. K., & Foo, K. Y. (2013) · Food Research International · doi:10.1016/j.foodres.2013.03.027 · Cited by 23
Varani, J., Bhagavathula, N., Ellis, C. N., & Pershadsingh, H. A. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.11.1453 · Cited by 20
“Using such tools, investigators have demonstrated that a number of biological effects mediated by these ligands occur in gene-deleted animals or in the presence of the receptor antagonists [63-65].”
BackgroundLee, J., Hong, E. M., Byun, H. W., Choi, M. H., Jang, H. J., Eun, C. S., Kae, S. H., & Choi, H. S. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-0029-5 · Cited by 20
Orphan nuclear receptors find a home in the arterial wall
Laffitte, B. A., & Tontonoz, P. (2002) · Current Atherosclerosis Reports · doi:10.1007/s11883-002-0022-6 · Cited by 22
Liu, X., Liu, H., Nie, H., Tian, L., Shi, Y., Lai, W., Xi, Z., & Lin, B. (2024) · Environmental Pollution · doi:10.1016/j.envpol.2024.125340 · Cited by 20
Zhu, Y., Ni, Y., Liu, R., Hou, M., Yang, B., Song, J., Sun, H., Xu, Z., & Ji, M. (2018) · Journal of Immunology Research · doi:10.1155/2018/6398078 · Cited by 23
“PPAR-γ can be expressed in macrophages [24, 25, 33], which are also the main cellular constituents of granulomas and important regulators in schistosomiasis [26, 27].”
BackgroundRen, Q., Xie, X., Zhao, C., Wen, Q., Pan, R., & Du, Y. (2022) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.2c00043 · Cited by 19
Vascular effects of PPARγ activators – From bench to bedside
Marx, N., & Walcher, D. (2007) · Progress in Lipid Research · doi:10.1016/j.plipres.2007.05.003 · Cited by 22
Lee, J., Hong, E. M., Koh, D. H., Choi, M. H., Jang, H. J., Kae, S. H., & Choi, H. S. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-0734-3 · Cited by 18
Halabi, C. M., & Sigmund, C. D. (2005) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200505060-00006 · Cited by 21
Robillard, R., Fontaine, C., Chinetti, G., Fruchart, J., & Staels, B. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-27661-0_14 · Cited by 25
Self-citationInoue, I., Hayashi, K., Yagasaki, F., Nakamura, K.-I., Matsunaga, T., Xu, H., Inukai, K.-I., Awata, T., Komoda, T., & Katayama, S. (2003) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.10.99 · Cited by 21
Zahradka, P. C., Yurkova, N., Litchie, B., Moon, M. C., Rizzo, D. F. D., & Taylor, C. G. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/a:1023424500160 · Cited by 19
Role of PNPLA3 in Hepatic Stellate Cells and Hepatic Cellular Crosstalk
Martins, M. C., Dixon, E. D., Lupo, G., Claudel, T., Trauner, M., & Rombouts, K. (2024) · Liver International · doi:10.1111/liv.16117 · Cited by 27
“In line, the activity of the nuclear receptor LXRα (liver X receptor alpha/ NR1H3), a downstream target of PPARγ [52, 53], was also reduced in PNPLA3 I148M expressing HSCs and in a stable over-expressing cell line [54].”
Ai, J., Ma, W., Pan, Z., Mao, B., Tang, X., Zhang, Q., Zhao, J., Chen, W., & Cui, S. (2023) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.12921 · Cited by 18
Rosiglitazone Enhances Apolipoprotein M (Apom) Expression in Rat's Liver
Luo, G., Feng, Y., Zhang, J., Mu, Q., Shi, Y., Qin, L., Zheng, L., Berggren-Söderlund, M., Nilsson‐Ehle, P., Zhang, X., et al. (2014) · International Journal of Medical Sciences · doi:10.7150/ijms.8330 · Cited by 18
Sueyoshi, S., Mitsumata, M., Kusumi, Y., Niihashi, M., Esumi, M., Yamada, T., & Sakurai, I. (2010) · Pathology - Research and Practice · doi:10.1016/j.prp.2010.01.010 · Cited by 20
Gao, D., Ashraf, M. Z., Zhang, L., Kar, N. S., Byzova, T. V., & Podrez, E. A. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.008445 · Cited by 20
Role of lycopene in smoke-promoted chronic obstructive pulmonary disease and lung carcinogenesis
Rakic, J. M., & Wang, X. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108439 · Cited by 20
Exposure to lipopolysaccharide induces immune genes in cultured preadipocytes of Atlantic salmon
Škugor, S., Škugor, A., Todorčević, M., Torgersen, J. S., Ruyter, B., & Krasnov, A. (2010) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2010.07.026 · Cited by 18
Kämmerer, I., Ringseis, R., & Eder, K. (2010) · British Journal Of Nutrition · doi:10.1017/s0007114510003478 · Cited by 18
PPAR agonists in health and disease: a pathophysiologic and clinical overview
Mudaliar, S. R. D., & Henry, R. R. (2002) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200208000-00002 · Cited by 19
Byun, H. W., Hong, E. M., Park, S. H., Koh, D. H., Choi, M. H., Jang, H. J., Kae, S. H., & Lee, J. (2014) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(14)60009-6 · Cited by 17
Wang, Z., Wang, M., Xu, X., Liu, Y., Chen, Q., Wu, B., & Zhang, Y. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.149128 · Cited by 19
Wu, J., Zhang, Y., Tang, H., & Ye, B. (2024) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.3c00731 · Cited by 17
Li, C., Tu, Y., Liu, T.-R., Guo, Z., Xie, D., Zhong, J., Fan, Y., & Lai, W. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2072 · Cited by 17
Effects of raloxifene on lipid and bone metabolism in postmenopausal women with type 2 diabetes
Mori, H., Okada, Y., Kishikawa, H., Inokuchi, N., Sugimoto, H., & Tanaka, Y. (2012) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-012-0379-8 · Cited by 18
Ivanov, S. M., Lagunin, A. A., Pogodin, P. V., Filimonov, D. A., & Poroikov, V. (2014) · Chemical Research in Toxicology · doi:10.1021/tx500147d · Cited by 17
PPARα-Dependent Modulation by Metformin of the Expression of OCT-2 and MATE-1 in the Kidney of Mice
Arruda, A. C., Perilhão, M. S., Santos, W. A., Gregnani, M. F., Budu, A., Neto, J. C. R., Estrela, G. R., & Araújo, R. C. (2020) · Molecules · doi:10.3390/molecules25020392 · Cited by 21
Wójcik, M., Mac‐Marcjanek, K., Nadel, I., Woźniak, L. A., & Cypryk, K. (2015) · Archives of Medical Science · doi:10.5114/aoms.2015.47692 · Cited by 17
New roles for PPARs in cholesterol homeostasis
Ricote, M., & Glass, C. K. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01802-2 · Cited by 16
Senanayake, S., Brownrigg, L. M., Panicker, V., Croft, K. D., Joyce, D. A., Steer, J. H., Puddey, I. B., & Yeap, B. B. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.07.009 · Cited by 19
Durán-Sandoval, D., Thomas, A.-C., Bailleul, B., Fruchart, J., & Staels, B. (2003) · médecine/sciences · doi:10.1051/medsci/20031989819 · Cited by 24
Self-citationMuralidhar, B., Carpenter, K. L. H., Müller, K. H., Skepper, J. N., & Arends, M. J. (2004) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2004.03.020 · Cited by 18
Chaya Leaf Decreased Triglycerides and Improved Oxidative Stress in Subjects With Dyslipidemia
Guevara‐Cruz, M., Vera, I., Cu-Cañetas, T. E., Cordero-Chan, Y., Torres, N., Tovar, A. R., Marquez-Mota, C. C., Talamantes-Gómez, J. M., Pérez‐Monter, C., Lugo, R., et al. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.666243 · Cited by 18
“The proposed molecular mechanism is the induction of ABCA1 gene expression by peroxisome proliferator-activated receptors -α and -γ in human macrophages and macrophage-derived foam cells, which promotes increased cholesterol flow from macrophages to the liver (50).”
BackgroundLiu, J., Zhang, W., Li, Y., Li, X., Li, Y., & Guo, F. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.153983 · Cited by 20
Sheng, R., Li, Y., Wu, Y., Liu, C., Wang, W., Han, X., Li, Y., Lei, L., Jiang, X., Zhang, Y., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116220 · Cited by 17
Fiévet, C., & Staels, B. (2009) · Current Atherosclerosis Reports · doi:10.1007/s11883-009-0043-5 · Cited by 19
Self-citationCTRP9 alleviates foam cells apoptosis by enhancing cholesterol efflux
Lei, S., Chen, J., Song, C., Li, J., Zuo, A., Xu, D., Li, T., & Guo, Y. L. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.111138 · Cited by 17
Xu, Y., Lai, F., Yang, X., Wu, Y., Liu, Q., Li, N., Wei, Y., Feng, T., Zheng, Z., Jiang, W., et al. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.10.002 · Cited by 16
Welters, H. J., Ouaamari, A. E., Kawamori, D., Meyer, J., Hu, J., Smith, D. M., & Kulkarni, R. (2012) · Endocrinology · doi:10.1210/en.2012-1243 · Cited by 20
Namgaladze, D., Morbitzer, D., von Knethen, A., & Brüne, B. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.199232 · Cited by 17
Wang, G., Han, T., Wang, S., Chen, M., Sun, Y., & Fu, Z. (2018) · BioMed Research International · doi:10.1155/2018/7475626 · Cited by 20
Xie, Y., Yang, Q., & DePierre, J. W. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04600.x · Cited by 18
Fibrate therapy in patients with metabolic syndrome and diabetes mellitus
Dayspring, T. D., & Pokrywka, G. S. (2006) · Current Atherosclerosis Reports · doi:10.1007/s11883-006-0032-x · Cited by 17
Beckman, J. A., Raji, A., & Plutzky, J. (2003) · Current Opinion in Cardiology · doi:10.1097/00001573-200311000-00009 · Cited by 17
Lipid lowering activity of drugs affecting cholesterol absorption
Norata, G. D., & Catapano, A. L. (2004) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/s0939-4753(04)80046-2 · Cited by 19
Fatty acids modulate the effect of darglitazone on macrophage CD36 expression
Svensson, L., Camejo, G., Cabré, A., Vallvé, J.-C., Pedreño, J., Norén, K., Wiklund, O., & Hultén, L. M. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01181.x · Cited by 16
Applegate, C. C., Kang, Y., Deng, H., Chen, D., Medina, N. G., Cui, Y., Feng, Y., Kuo, C.-W., Shahoei, S. H., Kim, H., et al. (2025) · Science Advances · doi:10.1126/sciadv.ads3731 · Cited by 19
“Agonism of PPARs α and γ (PPAR α / γ ) in M Φ s promotes fatty acid usage and storage, induces cholesterol efflux, and reduces foam cell formation ( 17, 18 ), inhibiting the development of atherosclerotic lesions ( 19, 20 ).”
Molecular, metabolic, and functional CD4 T cell paralysis in the lymph node impedes tumor control
Guo, M., Abd-Rabbo, D., Bertol, B. C., Carew, M., Lukhele, S., Snell, L. M., Xu, W., Boukhaled, G. M., Elsaesser, H. J., Halaby, M. J., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113047 · Cited by 19
“Intriguingly, PPAR γ , an important protein regulating the uptake of fatty acids and cholesterol balance in adipocytes and macrophages 32–35 was minimally upregulated in CD4 T TS cells compared with naive cells and was diminished compared with virus-specific CD4 Th1 and Tfh cells (Figures 3A–3C and…”
ResultAdiponectin-mediated regulation of the adiponectin cascade in cardiovascular disease: Updates
Hafiane, A. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.149406 · Cited by 17
Qian, T., Guo, D. S., Sun, L., Chi, M., Ma, X., & Jin, J. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1529924 · Cited by 18
Ma, L., Ballantyne, C. M., Belmont, J. W., Keinan, A., & Brautbar, A. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m028829 · Cited by 16
Tsunemi, A., Ueno, T., Fukuda, N., Watanabe, T., Tahira, K., Haketa, A., Hatanaka, Y., Tanaka, S., Matsumoto, T., Matsumoto, Y., et al. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1118-x · Cited by 17
Fang, J. S., Wang, F., Song, H., Wang, Z., Zuo, Z., Cui, H., Jia, Y., Deng, J., Yu, S., Hu, Y., et al. (2018) · Aging · doi:10.18632/aging.101623 · Cited by 15
“PPARα is a nuclear receptor that regulate lipid metabolism [10] and is also implicated in the development and intensity of inflammatory responses [11].”
BackgroundHussein, A., Fouda, K. A., Mehaya, F. M., Mohamed, D. A., Mohammad, A. A., Abdelgayed, S. S., & Mohamed, R. S. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e04593 · Cited by 17
“, 2008) through improving lipid metabolism, cell migration, apoptosis and inflammation as confirmed by Chinetti et al. (2001); Day et al. (2006); Ji et al. (2001), and Marx et al. (1999), respectively.”
BackgroundInfluentialSchirris, T. J. J., Rossell, S., de Haas, R., Frambach, S. J. C. M., Hoogstraten, C. A., Renkema, G. H., Beyrath, J., Willems, P. H. G. M., Huynen, M. A., Smeitink, J. A. M., et al. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.166062 · Cited by 15
Immune metabolism: a bridge of dendritic cells function
Sun, Y., Zhou, L., Chen, W., Zhang, L., Zeng, H., Sun, Y., Long, J., & Yuan, D. (2021) · International Reviews of Immunology · doi:10.1080/08830185.2021.1897124 · Cited by 18
Induction of ABCA1 by overexpression of hormone-sensitive lipase in macrophages
Tazoe, F., Yagyu, H., Okazaki, H., Igarashi, M., Eto, K., Nagashima, S., Inaba, T., Shimano, H., Osuga, J.-I., & Ishibashi, S. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.08.101 · Cited by 17
Balcerzyk, A., Żak, I., & Krauze, J. (2008) · Disease Markers · doi:10.1155/2008/789291 · Cited by 15
Yun, Y., Kim, H., & Song, Y. (2014) · Journal of Medicinal Food · doi:10.1089/jmf.2013.2943 · Cited by 15
Petty, H. R. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00032 · Cited by 15
Paraoxonase-1 and linoleic acid oxidation in familial hypercholesterolemia
van Himbergen, T. M., van Tits, L. J. H., Hectors, M. P. C., Graaf, J. D., Roest, M., & Stalenhoef, A. F. H. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.176 · Cited by 18
Johnston, T. P., & Waxman, D. J. (2008) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.60.6.0011 · Cited by 20
“…macrophages and macrophage-derived foam cells, PPARa activators induce ATP-binding cassette transporter A1 (ABCA1) gene expression through their inductive effects on the expression of liver X receptor alpha (LXRa) and promote cholesterol efflux to apolipoprotein (apo) A1 (Chinetti et al 2001).”
BackgroundGe, Z., Zhang, M., Deng, X., Zhu, W., Li, K., & Li, C. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.09.023 · Cited by 16
PPAR-γ Agonists: Shifting Attention from the Belly to the Heart?
van Wijk, J. P. H., & Rabelink, T. J. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000127311.38703.1f · Cited by 14
Wright, K., Mizzi, R., Plain, K. M., Purdie, A. C., & de Silva, K. (2022) · Scientific Reports · doi:10.1038/s41598-022-13503-8 · Cited by 15
Stifel, U., Caratti, G., & Tuckermann, J. P. (2022) · FEBS Letters · doi:10.1002/1873-3468.14474 · Cited by 16
Reddy, V. G., Laham, M. S., Lewandowski, C. T., Valencia‐Olvera, A. C., Balu, D., Moore, A., Ackerman-Berrier, M., Rychetsky, P., Penton, C., Musku, S. R., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00733 · Cited by 18
Chang, X., Feng, X., Li, S., Wang, J., Liu, P., & Wang, Y. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113629 · Cited by 16
Emerging options in the treatment of dyslipidemias: a bright future?
Florentin, M., Liberopoulos, E. N., Mikhailidis, D. P., & Elisaf, M. (2011) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2011.554395 · Cited by 14
Pinto, P. R., da Silva, K. S., Iborra, R. T., Okuda, L. S., Kjerulf, D. G., Ferreira, G. S., Machado‐Lima, A., Rocco, D. D. F. M., Nakandakare, E. R., Machado, U. F., et al. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00502 · Cited by 16
Lee, E., Shin, S., Lee, J., Lee, S.-J., Kim, J., Yoon, D., Woo, E., & Kim, Y. (2012) · Bulletin of the Korean Chemical Society · doi:10.5012/bkcs.2012.33.7.2219 · Cited by 14
Therapeutic Implications of PPAR γ in Cardiovascular Diseases
Hasegawa, H., Takano, H., & Komuro, I. (2010) · PPAR Research · doi:10.1155/2010/876049 · Cited by 18
“LXRα was recently identified as a direct target of PPARγ in mouse and human macrophages [49, 50].”
BackgroundIssa, C. T. M. I., Silva, A. S., Toscano, L. T., Medeiros, M. S., Persuhn, D. C., Diniz, A. D. S., Costa, M. J. D. C., & Gonçalves, M. D. C. R. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.04.020 · Cited by 16
Salacia – The new multi-targeted approach in diabetics
Vyas, N., Mehra, R., & Makhija, R. (2016) · AYU (An International Quarterly Journal of Research in Ayurveda) · doi:10.4103/ayu.ayu_134_13 · Cited by 15
Iron and Atherosclerosis: Nailing Down a Novel Target with Magnetic Resonance
Sharkey‐Toppen, T., Tewari, A. K., & Raman, S. V. (2014) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-014-9551-y · Cited by 17
Liver X receptors: Xcreting Xol to combat atherosclerosis
Francis, G. A., Annicotte, J., & Auwerx, J. H. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02400-0 · Cited by 14
Kanehara, H., Tohda, G., Oida, K., Suzuki, J., Ishii, H., & Miyamori, I. (2002) · Thrombosis Research · doi:10.1016/s0049-3848(03)00056-2 · Cited by 14
“However, it has been shown that activation of PPARg induces the ABCA1 transporter, which regulates reverse cholesterol transport in macrophages [38,39].”
BackgroundJawa, A., & Fonseca, V. A. (2005) · Cardiology Clinics · doi:10.1016/j.ccl.2004.06.001 · Cited by 14
Hu, Z., Yuan, Y.-Q., Tong, Z., Liao, M., Yuan, S., Jian, Y., Yang, J.-L., & Liu, W. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03529-y · Cited by 14
Drug repurposing by in silico prediction of cyclizine derivatives as antihyperlipemic agents
Afanamol, M. S., Dinesh, A. D., Ali, K. S., Vengamthodi, A., & Rasheed, A. (2023) · In Silico Pharmacology · doi:10.1007/s40203-023-00164-2 · Cited by 14
“The administration of PPAR-α agonists, such as fenofibrate, elicits the sole induction of LPL in the liver, resulting in a reduction of cholesterol levels (Chinetti et al. 2001).”
BackgroundE3317 promotes cholesterol efflux in macrophage cells via enhancing ABCA1 expression
Wang, X., Luo, J., Li, N., Liu, L., Han, X., Liu, C., Zuo, X., Jiang, X., Li, Y., Xu, Y., et al. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.08.125 · Cited by 13
Srivastava, N., Cefalu, A. B., Averna, M. R., & Srivastava, R. A. K. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01222 · Cited by 14
Murakami-Nishida, S., Matsumura, T., Senokuchi, T., Ishii, N., Kinoshita, H., Yamada, S., Morita, Y., Nishida, S., Motoshima, H., Kondo, T., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.04.229 · Cited by 14
Kotula‐Balak, M., Duliban, M., Pawlicki, P., Tuz, R., Bilińska, B., Płachno, B. J., Arent, Z., Krakowska, I., & Tarasiuk, K. (2020) · Acta Histochemica · doi:10.1016/j.acthis.2020.151526 · Cited by 14
Thiel, W. A., Esposito, E. J., Findley, A. P., Blume, Z. I., & Mitchell, D. M. (2022) · Biology Open · doi:10.1242/bio.058990 · Cited by 15
“This suggests that reported PPAR regulation of Abca1 (Chawla et al., 2001; Chinetti et al., 2001; Ogata et al., 2009) could differ amongst cell types or species, though it is also worth noting that the reported induction of Abca1 by PPAR receptors may involve PPAR-mediated induction of LXR (Kamijo…”
Toselli, F., de Waziers, I., Dutheil, M., Vincent, M., Wilce, P. A., Dodd, P. R., Beaune, P. H., Loriot, M., & Gillam, E. M. J. (2015) · Xenobiotica · doi:10.3109/00498254.2015.1040102 · Cited by 19
“However, PPARa regulates several other P450s that metabolize fatty acids (FAs) which are also substrates for CYP2J2 and CYP2U1 (Chinetti et al., 2001; Chuang et al., 2004; Wu et al., 1996).”
BackgroundYang, Y., Thyagarajan, N., Coady, B. M., & Brown, R. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.08.040 · Cited by 16
Versmissen, J., Oosterveer, D. M., Yazdanpanah, M., Mulder, M. T., Dehghan, A., Defesche, J. C., Kastelein, J. J. P., & Sijbrands, E. J. G. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq208 · Cited by 15
Metadata
- Authors
- Chinetti, G., Lestavel, S., Bocher, V., Remaley, A. T., Neve, B., Torra, I. P., Teissier, E., Minnich, A., Jaye, M., Duverger, N., Brewer, H. B., Fruchart, J.-C., Clavey, V., & Staels, B.
- Affiliations
- Inserm (FR)
- National Institutes of Health (US)
- Sanofi (France) (FR)
- Corresponding author
- Staels, Bart
- Venue
- Nature Medicine
- Published
- 2001-01
- Volume
- 7
- Issue
- 1
- Pages
- 53-58
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1524478189
- Cited by
- 1,170
- References
- 39
- Citations by year
- 2026: 12 · 2025: 29 · 2024: 31 · 2023: 41 · 2022: 25 · 2021: 28 · 2020: 30 · 2019: 20 · 2018: 29 · 2017: 31 · 2016: 38 · 2015: 33 · 2014: 50 · 2013: 37 · 2012: 38
- FWCI
- 99.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
- Keywords
- PPARα, PPARγ, ABCA1, cholesterol efflux, foam cells, macrophages, reverse cholesterol transport, liver X receptor alpha, apolipoprotein A-I, Tangier disease, acetylated LDL, CD36, THP-1 macrophages
- MeSH terms
- Base Sequence, Biological Transport, Cells, Cultured, Cholesterol, Foam Cells, Humans, Transcription Factors, DNA Primers, Receptors, Cytoplasmic and Nuclear, ATP-Binding Cassette Transporters, ATP Binding Cassette Transporter 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.